Skip to main content
Barry Porter

Dr Barry Porter

Commercial Portfolio Manager


Barry has over thirty years of drug discovery experience working in the pharmaceutical and allied industries.  Currently focusing on a portfolio of therapeutic opportunities from King’s Health Partners, he has previously been CEO of Union Life Sciences Ltd and ReOx Ltd.  He co-founded Curidium Medica plc and was Executive Chairman taking the Company to a public listing prior to its acquisition by Avacta plc.  He has sat as non-executive director on a number of Boards and prior to these roles, Barry held senior positions in both a Biotech (De Novo Pharmaceuticals Ltd, Pharmagene Ltd) and large Pharma (Sanofi and GlaxoSmithKline) environment.